Formulations for stabilizing fibroblast growth factor
Patent 5217954 Issued on June 8, 1993. Estimated Expiration Date: 
June 8, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
June 8, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesIsolation of fibroblast growth factor Preparation which promotes the absorption of peptides Isolation of fibroblast growth factor Patent #: 4902782 InventorsAssigneeApplicationNo. 504340 filed on 04/04/1990US Classes:514/12, 25 or more peptide repeating units in known peptide chain structure514/21, Produced by or extracted from animal tissue514/970, CONTAINING DESIGNATED INGREDIENT TO STABILIZE AN ACTIVE INGREDIENT530/399Hormones, e.g., prolactin, thymosin, growth factors, etc.ExaminersPrimary: Moezie, F. T.Attorney, Agent or FirmInternational ClassA61K 037/36AbstractPharmaceutical formulations and a method for their preparation are provided. These formulations provide a stabilized basic fibroblast growth factor (bFGF) which is less susceptible to oxidation or metal-induced aggregation by including an amount of a chelating agent effective to stabilize the bFGF.Other References
|
| ||||||||||||||
